We'll skip an introduction this week to save room for dessert, but suffice to say that several sponsors have something to be thankful for after US FDA approvals.
Keeping Track Of Approvals: Cancer, Cancer, And A Two-Week Cancer Review
The latest drug development news and highlights from our US FDA Performance Tracker.
